Abstract: The invention provides a genetic screening method for identifying a transfected cell expressing the polypeptide of interest. The methods allows for high throughput screening of recombinant cells for elevated levels of expression of the polypeptide of interest. The invention also provides capture media, formulations and methods of making and using thereof.

Abstract: A modular pegboard electrical board comprising an expandable grid of electrical leads to allow connection of various electronic implements, including light fixtures, fluorescent lamp ballasts and heating lamps. A rectangular pegboard having internal circuitry provides columns of electrical leads, whereby every four consecutive columns form a hot-ground-neutral-ground combination of vertical leads in parallel. The combination allows for connection of a two or three-wire interface to attach anywhere on the board surface, including electrical socket adapters and specific light fixture wiring. The pegboard-style board allows a latch mechanism from a light fixture or electrical device to affect an electrical connection at a specific lead.

Abstract: A modular pegboard electrical board comprising an expandable grid of electrical leads to allow connection of various electronic implements, including light fixtures, fluorescent lamp ballasts and heating lamps. A rectangular pegboard having internal circuitry provides columns of electrical leads, whereby every four consecutive columns form a hot-ground-neutral-ground combination of vertical leads in parallel. The combination allows for connection of a two or three-wire interface to attach anywhere on the board surface, including electrical socket adapters and specific light fixture wiring. The pegboard-style board allows a latch mechanism from a light fixture or electrical device to affect an electrical connection at a specific lead.

Abstract: The invention provides a genetic screening method for identifying a transfected cell expressing the polypeptide of interest. The methods allows for high throughput screening of recombinant cells for elevated levels of expression of the polypeptide of interest using methylcellulose comprising fluorescent protein A or G to improve detection and cloning. The invention also provides capture media, formulations and methods of making and using thereof.

Abstract: DNA sequences that increase peptide chain expression when operably linked to a gene encoding the peptide chain and methods of generating a peptide chain expression host cell using the foregoing are disclosed. Peptide chain expression host cells are also disclosed.

Abstract: DNA sequences that increase peptide chain expression when operably linked to a gene encoding the peptide chain and methods of generating a peptide chain expression host cell using the foregoing are disclosed. Peptide chain expression host cells are also disclosed.

Abstract: The present invention in the field of biotechnology, provides methods and compositions for providing enhanced growth of, and/or protein production from, cultured mammalian host cells used for the production of commercially useful amounts of expressed proteins, by the use of at least one Bcl2 encoding nucleic acid provided or transcribed in the host cell.

Abstract: The invention provides a genetic screening method for identifying a transfected cell expressing the polypeptide of interest. The methods allows for high throughput screening of recombinant cells for elevated levels of expression of the polypeptide of interest. The invention also provides capture media, formulations and methods of making and using thereof.

Abstract: The present invention relates to methods and compositions for chemically defined media for growth of mammalian cells for production of commercially useful amounts of expressed proteins.

Abstract: A porous media gas burner is adapted to operate in a pressurized environment. The burner may have three zones: a mixing zone, an ignition zone and a reaction zone. The burner may be used as a downhole burner in a formation heat treatment method for oil and gas wells.

Abstract: The present invention relates to clonal myeloma cell lines that have the ability to grow continuously in chemically defined media. The present invention also relates to the production of proteins in clonal myeloma cell lines and any cell lines derived therefrom. The present invention further relates to methods for identifying cell lines capable of growing in chemically defined media.

Abstract: The present invention in the field of biotechnology, provides methods and compositions for providing enhanced growth of, and/or protein production from, cultured mammalian host cells used for the production of commercially useful amounts of expressed proteins, by the use of at least one Bcl2 encoding nucleic acid provided or transcribed in the host cell.

Abstract: The present invention relates to clonal myeloma cell lines that have the ability to grow continuously in chemically defined media. The present invention also relates to the production of proteins in clonal myeloma cell lines and any cell lines derived therefrom. The present invention further relates to methods for identifying cell lines capable of growing in chemically defined media. The present invention also relates to business methods where customers are provided with the cells, cell lines, and cell cultures of the present invention.

Abstract: The present invention provides a novel myeloma cell line, designated C463A, and derivatives of C463A, which have the ability to grow continuously in chemically defined media. The present invention also relates to the production of proteins in cell line C463A and any cell line derived therefrom. The present invention further relates to methods for identifying cell lines capable of growing in chemically defined media. The present invention also relates to business methods where customers are provided with the cells, cell lines, and cell cultures of the present invention.

Abstract: The present invention relates to methods and compositions for chemically defined media for growth of mammalian cells for production of commercially useful amounts of expressed proteins.